Cardiorenal consequences of atherosclerosis and statins therapy: from the past to the future
- PMID: 16305524
- DOI: 10.2174/138161205774580589
Cardiorenal consequences of atherosclerosis and statins therapy: from the past to the future
Abstract
Complications from atherosclerosis cause most deaths in western countries, and their incidence appears to be markedly increasing in developing countries, thus suggesting a correlation that is directly proportional to social progress. In recent years, the different branches of medical research, from studies on vascular disease to those on lipid and glucose metabolism, and also clinical research on coronary, carotid and peripheral artery diseases, epidemiologic and pharmacologic research, have concentrated on these diseases with the common aim of reducing the incidence of cardiovascular diseases, and mortality. Scientific progress has greatly improved our understanding of the pathogenic mechanisms underlying the progression of cardiovascular disease, and efforts in this discipline now appear more necessary than ever.
Similar articles
-
Basic science review: Statin therapy--Part I: The pleiotropic effects of statins in cardiovascular disease.Vasc Endovascular Surg. 2010 May;44(4):241-51. doi: 10.1177/1538574410362922. Vasc Endovascular Surg. 2010. PMID: 20403949 Review.
-
Statins and stroke prevention.Cerebrovasc Dis. 2007;24(2-3):170-82. doi: 10.1159/000104474. Epub 2007 Jun 27. Cerebrovasc Dis. 2007. PMID: 17596685 Review.
-
Regression or reduction in progression of atherosclerosis, and avoidance of coronary events, with lovastatin in patients with or at high risk of cardiovascular disease: a review.Clin Drug Investig. 2007;27(9):591-604. doi: 10.2165/00044011-200727090-00001. Clin Drug Investig. 2007. PMID: 17705568 Review.
-
New nonlipid effects of statins and their clinical relevance in cardiovascular disease.Thromb Haemost. 2004 Jun;91(6):1065-77. doi: 10.1160/TH04-02-0064. Thromb Haemost. 2004. PMID: 15175791 Review.
-
The treatment of coronary heart disease: an update. Part 3: Statins beyond cholesterol lowering.Curr Med Res Opin. 2001;17(1):34-7. Curr Med Res Opin. 2001. PMID: 11464443
Cited by
-
Hypolipidemic agent Z-guggulsterone: metabolism interplays with induction of carboxylesterase and bile salt export pump.J Lipid Res. 2012 Mar;53(3):529-539. doi: 10.1194/jlr.M014688. Epub 2012 Jan 14. J Lipid Res. 2012. PMID: 22246918 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous